Important NoticeThis app is for educational purposes only. You must be 18+ to use it. We do not sell any peptides on this site.

Research Use Only - Important Disclaimer

All products listed on this website are intended for laboratory research use only and are not for human consumption, medical, veterinary, or household use. These products should only be handled by qualified professionals. We do not provide any dosage information, and the products must not be used as food additives, drugs, cosmetics, or for any other inappropriate applications. By purchasing, you acknowledge and agree to these terms.

Vial

Cagrisema Sodium

Peptide Compound for Metabolic ResearchFor research use only
View

Cagrisema is a co-formulation of cagrilintide and semaglutide, combining the effects of amylin and GLP-1 receptor agonism for enhanced weight loss and glycemic…

Half-life

5–7 days (approximate)

Delivery

Subcutaneous injection

Suggested dosage

Not specified

Usage

Used in research on obesity, appetite regulation, and glucose metabolism. Promising results in weight loss and Type 2 diabetes models.

Mechanism of action

Combines GLP-1 receptor activation with amylin receptor activity to suppress appetite, slow gastric emptying, and improve metabolic parameters.

Benefits (4)

  • Appetite suppression
  • Weight reduction
  • Improved glucose control
  • Delayed gastric emptying

Side effects (4)

  • Nausea
  • Constipation
  • Loss of appetite
  • Mild gastrointestinal discomfort
No purchase links available